Carmell Therapeutics Corp...
0.53
7.07%
At close: Jan 13, 2025, 3:00 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21
Cash & Equivalents 2.91M 128.15K 12.36K
Short-Term Investments n/a n/a n/a
Long-Term Investments n/a 156.69M 154.45M
Other Long-Term Assets n/a -156.69M -154.45M
Receivables 204.56K n/a n/a
Inventory n/a n/a n/a
Other Current Assets 59.78M 83.24K 198.98K
Total Current Assets 62.90M 605.54K 178.70K
Property-Plant & Equipment 1.02M 1.11M 1.35M
Goodwill & Intangibles 24.19K 28.70K 33.22K
Total Long-Term Assets 1.05M 1.14M 1.38M
Total Assets 63.95M 1.75M 1.56M
Account Payables 4.42M 2.14M 871.31K
Deferred Revenue n/a 1.39M 2.37M
Short-Term Debt 1.44M 2.91M 8.72M
Other Current Liabilities 32.65M 1.86M 6.21M
Total Current Liabilities 38.50M 7.30M 15.80M
Long-Term Debt 697.72K 827.73K 962.83K
Other Long-Term Liabilities n/a 31.42M 14.37M
Total Long-Term Liabilities 697.72K 32.24M 15.33M
Total Liabilities 39.20M 39.54M 31.13M
Total Debt 2.14M 3.74M 9.69M
Common Stock 2.31K 14.53K 36.92K
Retained Earnings -58.50M -42.38M -32.77M
Comprehensive Income n/a -31.42M n/a
Shareholders Equity 24.75M -37.79M -29.58M
Total Investments n/a 156.69M 154.45M